Biointron closes $72m and 21 more deal updates from Greater China worth $280m

Biointron closes $72m and 21 more deal updates from Greater China worth $280m

Biointron, a Chinese contract research organisation (CRO) that serves life science researchers and biopharmaceutical companies, has secured almost 500 million yuan ($72.4 million) in a Series B funding round to expand its operations.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter